Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Pharma Industry News Is AFT Pharmaceuticals undervalued after NZ$208m in FY25 Revenue? What’s next for AFP stock AFT Pharmaceuticals posts NZ$208M record revenue in FY25. Find out why investors are eyeing its NZ$300M growth target despite short-term profit dips. byPallavi MadhirajuMay 22, 2025